Skip Navigation
Skip to contents

Ann Occup Environ Med : Annals of Occupational and Environmental Medicine

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Safurah Jaafar 1 Article
Workplace influenza vaccination in private hospital setting: a cost-benefit analysis
Mohd. Ab. Hadi Tohiar, Safurah Jaafar, Azimatun Noor Aizuddin, Tan Kok Leong, Azrin Syahida Abdul Rahim
Ann Occup Environ Med 2022;34:e3.   Published online February 17, 2022
DOI: https://doi.org/10.35371/aoem.2022.34.e3
AbstractAbstract PDFPubReaderePub
Background

Influenza illness causes several disruptions to the workforce. The absenteeism that often ensues has economic implications for employers. This study aimed to estimate the cost-benefit of influenza vaccination in a healthcare setting from the employer’s perspective.

Methods

A cross-sectional questionnaire survey was conducted in a private hospital in 2018–2019 comparing voluntary vaccinated with non-vaccinated employees with influenza vaccine. The analyses were made based on self-reporting on absenteeism and presenteeism from Influenza-like illnesses (ILIs). The costs incurred, both direct and indirect costs, were included in the study. A cost-benefit analysis was performed by measuring the cost of the vaccination program. The costs of absenteeism and reduced productivity were calculated using 3 hypothesised levels of effectiveness in the following percentage of productivity of 30%, 50%, and 70%. The costs were also calculated based on four scenarios: with and without operating income and with and without replacement. The benefits of the influenza vaccination from the employer’s perspective were analysed. The benefit to cost ratio was determined.

Results

A total of four hundred and twenty-one respondents participated. The influenza vaccination rate was 63.0%. The rate of ILI of 38.1% was significantly lower among vaccinated. The ILI-related absenteeism reported was also significantly lower amongst vaccinated employees at 30% compared to 70% non-vaccinated. Employers could save up to USD 18.95 per vaccinated employee when only labour cost was included or 54.0% of cost savings. The cost-saving rose to USD 155.56 when the operating income per employee was also included. The benefit to cost ratio confirmed that the net cost-benefit gained from the vaccination was more than the net cost of vaccination.

Conclusions

Influenza vaccination for working adults was cost-saving and cost-beneficial when translated into financial investments for the employer. A workplace vaccination demonstrates a significant cost-benefit strategy to be applied in any institutional setting.


Citations

Citations to this article as recorded by  
  • Association between long working hours and engagement in preventive healthcare services in Korean workers: Findings from the Korean National Health and Nutrition Examination Survey
    Seong-Uk Baek, Yu-Min Lee, Jin-Ha Yoon
    Preventive Medicine.2024; 180: 107849.     CrossRef
  • Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022
    Radhika Gharpure, Anna N. Chard, Maria Cabrera Escobar, Weigong Zhou, Molly M. Valleau, Tat S. Yau, Joseph S. Bresee, Eduardo Azziz-Baumgartner, Sarah W. Pallas, Kathryn E. Lafond, Sydney Rosen
    PLOS Medicine.2024; 21(1): e1004333.     CrossRef
  • 50 View
  • 0 Download
  • 2 Web of Science
  • 2 Crossref
Close layer

Ann Occup Environ Med : Annals of Occupational and Environmental Medicine
Close layer
TOP